[Pharmwaste] Re: Pharmwaste Digest, Vol 107, Issue 21
Jim Mullowney
jmullowney at pharma-cycle.com
Tue Sep 16 17:33:04 EDT 2014
Ron, you should read the attached study done by a division of Deloitte in Paris. There are over 500 references.
1. As far as your question on excreted drugs and metabolites that information comes from the FDA on every drug, check the next time you get a prescription, it will tell you how much comes out in the urine and feces and how quickly.
2. Degradation of Cyclophosphamide and Ifosphamide have been studied extensively as well as other chemotherapy drugs. The EU study covers that and can dig those out for you.
3. There are many studies that show cyclophosphamide (U058) and Acrolein (P003) the main metabolite in the water (page 81 of the attached study)
4. I think in your last sentence you may be looking at drugs as persistent organic compounds, this is a problem because they are polar and completely water soluble. The EU report states exactly that and that current modeling does not work ( I take this as a statement that traditional toxicology modeling does not work for drugs)
Hope that was helpful.
Jim
From: pharmwaste-bounces at lists.dep.state.fl.us [mailto:pharmwaste-bounces at lists.dep.state.fl.us] On Behalf Of Ronald Ney
Sent: Saturday, September 13, 2014 10:59 AM
To: pharmwaste at lists.dep.state.fl.us
Subject: [Pharmwaste] Re: Pharmwaste Digest, Vol 107, Issue 21
I have yet to see data on metabolites secreted or degradation of parent and metabolites in the environment by photodegradation, pH, microbial degradation. Are there analytes for parent and degradation products? Have the extraction methods be proven that parent and degradates can be extracted over time and that they are not adsorbed in the media tested?
Ron Ney
On Sat, Sep 13, 2014 at 12:58 AM, <pharmwaste-request at lists.dep.state.fl.us> wrote:
Send Pharmwaste mailing list submissions to
pharmwaste at lists.dep.state.fl.us
To subscribe or unsubscribe via the World Wide Web, visit
http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste
or, via email, send a message with subject or body 'help' to
pharmwaste-request at lists.dep.state.fl.us
You can reach the person managing the list at
pharmwaste-owner at lists.dep.state.fl.us
When replying, please edit your Subject line so it is more specific
than "Re: Contents of Pharmwaste digest..."
Today's Topics:
1. excreted drugs & whole effluent toxicity? (Gilliam, Allen)
2. NIOSH Updates Hazardous Drug List 2014 (Jeff Hollar)
3. RE: excreted drugs & whole effluent toxicity? (Jim Mullowney)
---------- Forwarded message ----------
From: "Gilliam, Allen" <GILLIAM at adeq.state.ar.us>
To: "'pharmwaste at lists.dep.state.fl.us'" <pharmwaste at lists.dep.state.fl.us>
Cc: "Glassmeyer.susan at Epa.gov" <Glassmeyer.susan at epa.gov>
Date: Fri, 12 Sep 2014 09:40:31 -0500
Subject: [Pharmwaste] excreted drugs & whole effluent toxicity?
Fellow Pharma folks,
Sorry for getting off the take-back programs for just a minute.
Maybe most of you have already seen this, but Dr. Christian Daughton recently authored this Eco-directed sustainable prescribing: feasibility for reducing water contamination by drugs @ <http://dx.doi.org/10.1016/j.scitotenv.2014.06.013> http://dx.doi.org/10.1016/j.scitotenv.2014.06.013 . Its abstract itself may take a few readings to understand (at least it did for me), but I believe the underlying concept of the manuscript is P2’s source reduction.
I only briefly scanned several pages of its content and is way above this mechanical engineer’s head. For those of you familiar with pharmacokinetics, you may be able to glean some important themes in the Dr’s contentions.
Add another acronym to your vocabulary if you haven’t already because Biopharmaceutics Drug Disposition Classification System (BDDCS) runs throughout its core.
I would expect a brief synopsis from our dear friend, Dr. Charlotte Smith in a few weeks.
My original e-mail’s intent to several experts on this issue was mainly to discover which analytical methods could be used to measure low level APIs (which method measure what APIs or their metabolites?); therefore, helping to determine if their presence could potentially be the toxicant(s) in cities’ WET sublethality failures (growth and reproductivity).
Dr. Susan Glassmeyer, e-cc’d above was suggested as a good source by Dr. Daughton. Dr. Glassmeyer? Would you please respond in some manner? I’d love for more cities to get involved with their own w.w. treatment plant’s effluent quality. Heretofore, most cities in the US are not sampling/analyzing for APIs or their metabolites. At least I have seen very few reports about them except through the USGS.
Ciao,
Allen Gilliam
ADEQ State Pretreatment Coordinator
501.682.0625
---------- Forwarded message ----------
From: Jeff Hollar <jhollar at pwaste.com>
To: <pharmwaste at lists.dep.state.fl.us>
Cc:
Date: Fri, 12 Sep 2014 10:43:21 -0500
Subject: [Pharmwaste] NIOSH Updates Hazardous Drug List 2014
27 new drugs added and 12 drugs removed. We have incorporated these changes in our database.
http://www.cdc.gov/niosh/docs/2014-138/pdfs/2014-138.pdf
Jeff Hollar
President
PharmWaste Technologies, Inc.
4164 NW Urbandale Dr., Ste A
Urbandale, IA 50322
515-276-5302 (general)
515-331-7310 (direct)
515-360-9785 (cell)
www.pwaste.com <http://www.pwaste.com/>
---------- Forwarded message ----------
From: Jim Mullowney <jmullowney at pharma-cycle.com>
To: "'Gilliam, Allen'" <GILLIAM at adeq.state.ar.us>, <pharmwaste at lists.dep.state.fl.us>
Cc: Glassmeyer.susan at epa.gov
Date: Fri, 12 Sep 2014 11:45:37 -0400
Subject: RE: [Pharmwaste] excreted drugs & whole effluent toxicity?
What I took from Dr. Daughton’s report is that the way to reduce the effects of drugs in the environment is to lower the dose administered to the patient because drugs are in the environment from human excretion.
He further states:
“Certain drug classes (especially cytotoxic chemotherapeutics) may not be amenable to this approach; the best control measure for such highly toxic drugs may simply be the prevention of urine and feces from entering sewers”
There are 27 cytotoxic chemotherapy drugs that are heavily excreted (I attached the list) and need to be collected for 48 hours after infusion according to the World Health Organization. Go to www.cytotoxicsafety.com to see how to easily control human waste with cytotoxic chemotherapy drugs.
Jim Mullowney
From: pharmwaste-bounces at lists.dep.state.fl.us [mailto:pharmwaste-bounces at lists.dep.state.fl.us] On Behalf Of Gilliam, Allen
Sent: Friday, September 12, 2014 10:41 AM
To: 'pharmwaste at lists.dep.state.fl.us'
Cc: Glassmeyer.susan at Epa.gov
Subject: [Pharmwaste] excreted drugs & whole effluent toxicity?
Fellow Pharma folks,
Sorry for getting off the take-back programs for just a minute.
Maybe most of you have already seen this, but Dr. Christian Daughton recently authored this Eco-directed sustainable prescribing: feasibility for reducing water contamination by drugs @ <http://dx.doi.org/10.1016/j.scitotenv.2014.06.013> http://dx.doi.org/10.1016/j.scitotenv.2014.06.013 . Its abstract itself may take a few readings to understand (at least it did for me), but I believe the underlying concept of the manuscript is P2’s source reduction.
I only briefly scanned several pages of its content and is way above this mechanical engineer’s head. For those of you familiar with pharmacokinetics, you may be able to glean some important themes in the Dr’s contentions.
Add another acronym to your vocabulary if you haven’t already because Biopharmaceutics Drug Disposition Classification System (BDDCS) runs throughout its core.
I would expect a brief synopsis from our dear friend, Dr. Charlotte Smith in a few weeks.
My original e-mail’s intent to several experts on this issue was mainly to discover which analytical methods could be used to measure low level APIs (which method measure what APIs or their metabolites?); therefore, helping to determine if their presence could potentially be the toxicant(s) in cities’ WET sublethality failures (growth and reproductivity).
Dr. Susan Glassmeyer, e-cc’d above was suggested as a good source by Dr. Daughton. Dr. Glassmeyer? Would you please respond in some manner? I’d love for more cities to get involved with their own w.w. treatment plant’s effluent quality. Heretofore, most cities in the US are not sampling/analyzing for APIs or their metabolites. At least I have seen very few reports about them except through the USGS.
Ciao,
Allen Gilliam
ADEQ State Pretreatment Coordinator
501.682.0625
---
Note: As a courtesy to other listserv subscribers, please post messages to the listserv in plain text format to avoid the garbling of messages received by digest recipients.
---
TO SUBSCRIBE, go to: http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste
TO UNSUBSCRIBE, DO NOT REPLY TO THE LISTSERV. Please send an e-mail to pharmwaste-unsubscribe at lists.dep.state.fl.us -- the subject line and body of the e-mail should be blank.
If you believe you may be subscribed with a different email address, please visit the subscriber listing at http://lists.dep.state.fl.us/cgi-bin/mailman/roster/pharmwaste
FOR PROBLEMS: Contact List Administrator Laurie.Tenace at dep.state.fl.us
SEND MAIL to the list server at: pharmwaste at lists.dep.state.fl.us
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20140916/9795087e/attachment-0001.htm
-------------- next part --------------
A non-text attachment was scrubbed...
Name: Highlighted EU study_environment.pdf
Type: application/pdf
Size: 3462264 bytes
Desc: not available
Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20140916/9795087e/HighlightedEUstudy_environment-0001.pdf
More information about the Pharmwaste
mailing list